BioNTech Sets Cancer-Drug Deal With Bristol Myers Squibb
Latest News
- How GM + Nvidia are changing the face of the automotive industry
- Truckload’s path to equilibrium
- AI’s Potential Marketing Payoffs Come With Outsize Brand Risks
- Daily Spotlight: Argus Adjusts S&P 500 EPS Estimates
- IRH to buy Tremont’s majority interest in Alphamin Resources
- Circle Prices IPO Above Range. The Stock Looks Set to Jump When It Starts Trading Today.